GlobeNewswire

Kratos to Unveil Newest High Performance Class of Military Unmanned Aerial System Technology at 2017 Paris Air Show

Dela

Low-Cost, High-Performance Craft Represent Next Generation of Military Drones

SAN DIEGO, June 13, 2017 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, today announced the company will officially unveil a new class of unmanned aerial systems that represent the future of air combat at the 2017 Paris Air Show. Kratos is at the forefront of unmanned aerial systems with its ability to rapidly design, develop, demonstrate and deliver affordable high-performance jet powered drones.

Photos accompanying this announcement are available at 
http://www.globenewswire.com/NewsRoom/AttachmentNg/7d1c48b9-07d0-4ae1-9704-646f51a30f32 http://www.globenewswire.com/NewsRoom/AttachmentNg/96fb3aca-7dfe-470c-b662-436d7edd7286 http://www.globenewswire.com/NewsRoom/AttachmentNg/0a6629dc-e064-47b2-bb14-7909905913db http://www.globenewswire.com/NewsRoom/AttachmentNg/caf99365-ca62-415f-a9d3-205b812d0014

At the show, Kratos will be presenting the XQ-222 Valkyrie and UTAP-22 Mako drones that provide fighter-like performance and are designed to function as wingmen to manned aircraft in contested airspace.

The Valkyrie and the Mako represent the next generation of UAVs. They are highly maneuverable, stealthy, able to fly at near supersonic speeds, and can carry and deploy weapons or surveillance systems. The larger Valkyrie, measuring in at roughly 30 feet in length, has an impressive range of more than 3,000 nautical miles.

Most important, Kratos' UAVs are aligned with emerging military strategies because they are reusable and lower priced -- in the $2 million to $3 million range. This makes it cost efficient to deploy them in numbers that can effectively support manned aircraft or operate independently in combat.

The Valkyrie was recently announced by the Air Force Research Labs (AFRL) at a presentation on its Low Cost Attritable Aircraft Technology (LCAAT) program at Wright Patterson Air Force Base. 

"If you team up a bunch of these aircraft with an F-35 or an F-22, or some of our surveillance assets, you'd basically be able to cover more space at a lower cost point," Bill Baron, AFRL LCAAT project manager, told the Dayton Daily News at the May 9 event. "In a lot of cases, we don't have enough airplanes and as you look to the future, most likely our fleet sizes are going to continue to be more limited so this is a way to provide a force multiplier."

The Valkyrie has been in development since July 2016, when the U.S. Air Force awarded Kratos a contract to develop the LCAAT. After a less-than-two-year design and development effort, the Valkyrie is scheduled for its first flight in spring of 2018. The Mako is already operational and is scheduled for follow-on test flights, where it will carry sensors and be teamed with manned aircraft, in June, July and August of this year.

"The Mako and Valkyrie represent an entirely new category of UAVs," said Eric Demarco, Kratos CEO. "Thanks to our target drone expertise and our in-house research and development team, we have been able to combine high performance with low cost in fully functioning aircraft. And we did it in less than two years, not decades."

The Paris Air Show is the largest aerospace event in the world and will be held June 19-25. Kratos will be hosting visitors at booth # 3 A118.

About Kratos 
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops transformative technology for the Department of Defense and commercial customers. Kratos is changing the way breakthrough technology for these industries is brought to market through proactive research and a streamlined development process. Kratos specializes in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense and combat systems. For more information, go to www.kratosdefense.com

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
investor@kratosdefense.com

Press Contact: 
Jon Schmid 
619-200-7257 
JSchmid@CookandSchmid.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kratos Defense & Security Solutions, Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum